Ditazol or ditazole
- Level
- Commodity
- Parent
- 51131600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51131634This classification denotes an antiplatelet agent with the molecular formula C19H20N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H2BQI5Z8FT, chemically known as 4,5-diphenyl-2-bis(2-hydroxyethyl)-aminoxazol but generally known as ditazol, which bears US NIH Compound Identifier 29088. European Medicines Agency schedules Ditazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06328MIG. The term DITAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 23, No. 10 1969, List 9). World Health Organization schedules ditazol in its Anatomical Therapeutic Chemical (ATC) Classification. Ditazol or ditazole bears US NLM identifiers UMLS ID C0012777 and NCI Concept Code C65442. SMILES: C1=CC=C(C=C1)C2=C(OC(=N2)N(CCO)CCO)C3=CC=CC=C3.
Same parent
Under 51131600 · 61Activities that produce or sell this
KBLI · 8Inherited from family 51130000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.